Results 11 to 20 of about 25,813 (258)

LDL Apheresis and Lp (a) Apheresis: A Clinician’s Perspective [PDF]

open access: yesCurrent Atherosclerosis Reports, 2021
Lipoprotein apheresis is the most effective means of lipid-lowering therapy. However, it's a semi-invasive, time consuming, and chronic therapy with variable adherence. There are still no specific guideline recommendations for the management of patients on lipid apheresis.

exaly   +4 more sources

ABO-incompatible kidney transplantation: impact of apheresis on graft and patient survival in recipients with low isoagglutinin titer [PDF]

open access: yesTransplant International
ABO-incompatible (ABOi) kidney transplantation carries a high risk of acute antibody-mediated rejection due to the presence of isoagglutinins. To mitigate this risk, current protocols recommend performing apheresis before transplantation.
Marion Mangin   +14 more
doaj   +2 more sources

Retrospective Evaluation of Dual Specialty Ports in Therapeutic Apheresis [PDF]

open access: yesJ Clin Apher
Dual specialty ports were evaluated for safety and efficacy in therapeutic apheresis by analyzing outcomes across 97 port placement events in 88 patients, focusing on two configurations: dual Bard PowerFlow (BP2) and a combination of Bard PowerFlow with ...
Obeng-Gyasi, Barnabas   +3 more
core   +2 more sources

Assessment of the efficacy of large volume delayed sampling primary culture and pathogen reduction in preventing septic reactions from platelet transfusions [PDF]

open access: yesTransfusion, Volume 66, Issue 9, Page 1846-1859, September 2026.
Abstract Background Many mitigation processes have been introduced to reduce septic transfusion reactions (STRs) caused by the transfusion of bacterially contaminated PLTs. Methods The efficacy of primary culture and pathogen reduction is assessed in this review using data from long‐term hemovigilance programs in the US, Canada, UK, France, Switzerland,
Michael R. Jacobs
wiley   +2 more sources

Tocilizumab in the Treatment of Chronic Antibody-Mediated Rejection Post Kidney Transplantation: Clinical and Histological Monitoring

open access: yesFrontiers in Medicine, 2021
Introduction: Chronic antibody-mediated rejection (cAMR) has very few effective therapeutic options. Interleukin-6 is an attractive target because it is involved in inflammation and humoral immunity.
Johan Noble   +11 more
doaj   +1 more source

Very Early Severe Posttransplant Recurrent Antineutrophil Cytoplasmic Antibody-Associated Glomerulonephritis after Kidney Transplantation: Two Case Reports

open access: yesCase Reports in Nephrology, 2022
Successful kidney transplantation (KTx) in patients with antineutrophil cytoplasmic antibody-associated vasculitis (AAV) has been reported with excellent patient and graft survival rates.
Reda Laamech   +7 more
doaj   +1 more source

Clinical frailty assessment might be associated with mortality in incident dialysis patients

open access: yesScientific Reports, 2022
Frailty is associated with mortality in maintenance dialysis patients. For incident dialysis patients, we used the clinical frailty scale (CFS) to investigate frailty as related to mortality or hospitalization within 2 years.
Rikako Oki   +10 more
doaj   +1 more source

The scientific basis and future of lipoprotein apheresis [PDF]

open access: yes, 2021
Lipoprotein apheresis plays a vital role in the management of the severe hyperlipidemias that predispose to atherosclerosis. Determinants of efficacy are the acute reduction in lipoproteins achieved by each apheresis procedure, their frequency, and the ...
Gilbert R. Thompson, Thompson, Gilbert R
core   +1 more source

Time until treatment initiation is associated with catheter survival in peritoneal dialysis-related peritonitis

open access: yesScientific Reports, 2021
For peritonitis, a serious complication of peritoneal dialysis (PD), we investigated the relation between duration from the sign (PD effluent abnormalities) to treatment with appropriate antibiotics (ST time) and catheter removal.
Rikako Oki   +9 more
doaj   +1 more source

Prevalence of diarrhea in end-stage renal disease patients initiating hemodialysis

open access: yesRenal Replacement Therapy, 2021
Background Diarrhea is one of the symptoms occasionally seen in patients initiating hemodialysis. When they have diarrhea, they need several additional cares for defecation during the hemodialysis sessions and for infection control at dialysis facilities.
Miho Oba   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy